Advent International, L.P. - Sep 15, 2021 Form 3 Insider Report for Definitive Healthcare Corp. (DH)

Signature
ADVENT INTERNATIONAL CORPORATION, By: /s/ Neil Crawford, Name: Neil Crawford, Title: Director, Fund Administration
Stock symbol
DH
Transactions as of
Sep 15, 2021
Transactions value $
$0
Form type
3
Date filed
9/15/2021, 08:44 PM
Previous filing
Aug 9, 2021
Next filing
Sep 21, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding DH Class A Common Stock 66.1M Sep 15, 2021 See notes F1, F2, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 See Exhibit 99.1 for text of footnote (1).
F2 See Exhibit 99.1 for text of footnote (2).
F3 See Exhibit 99.1 for text of footnote (3).
F4 See Exhibit 99.1 for text of footnote (4).

Remarks:

Christopher Egan, a Managing Partner of Advent and Lauren Young, a Managing Director of Advent (together, the "Advent Directors"), each serve on the board of directors of the Issuer, and have been deputized to represent the Reporting Persons on the board of directors. By virtue of the Advent Directors' representation, for purposes of Section 16 of the Securities Exchange Act of 1934, each of the Reporting Persons may be deemed directors by deputization of the Issuer. The Advent Directors have filed separate Section 16 reports disclosing securities of the Issuer that they may be deemed to beneficially own for Section 16 purposes. Exhibit 99.1 (Footnotes to Form 3) and Exhibit 99.2 (Signatures and Joint Filer Information) are incorporated by reference. Form 4 of 5: This Form 3 is the fourth of five Forms 3 being filed relating to the same event. The Form 3 has been split into multiple filings because there are more than 10 Reporting Persons total, and the SEC's EDGAR filing system limits a single Form 3 to a maximum of 10 Reporting Persons. Each Form 3 will be filed by Designated Filer Advent International Corporation.